Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Moussa, Chirine; Esbaa, Samia; Rouis, Houda; Sellami, Nada; Hajji, Meriam; Houcine, Yoldez; Khattab, Amel; Khouaja, Ibtihel; Zendah, Ines; Maâlej, Sonia

doi:10.1002/rcr2.1190

Respirology Case Reports

2023

DOI: 10.1002/rcr2.1190

|View full text |Cite

Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Chirine Moussa,

Samia Esbaa,

Houda Rouis

et al.

Abstract: Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Ethambutol/isoniazid/rifampicin

2023

Reactions Weekly

View full text Add to dashboard Cite

Ethambutol/isoniazid/rifampicin

2023

Reactions Weekly

View full text Add to dashboard Cite

Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia

Thakare,

Jamale,

Memon

2024

Best Practice & Research Clinical Endocrinology & Metab

View full text Add to dashboard Cite

Continuous Rifampicin Therapy Induced Acute Kidney Injury in a Tuberculous Patient: A Case Report

Shaukat,

Ali,

Irtaza

et al. 2024

Int J Med Stud

View full text Add to dashboard Cite

Background: Tuberculosis (TB) presents with productive cough, hemoptysis, chest pain, fever, weight loss, and night sweats. Anti-tuberculosis treatment (ATT) can affect various organs, including the liver and kidneys. ATT-induced acute kidney injury (AKI) presents with fever, rash, nausea, vomiting, diarrhea, and abdominal pain. It occurs due to type 2 or 3 hypersensitivity and affects individuals who have previously used rifampicin or are currently using it intermittently. Case: An 60-year-old lady was diagnosed with TB and started on ATT. After a few days, she complained of reduced food intake and vomiting, yellow discoloration of the skin, abdominal pain and distention, and limb swelling. She was diagnosed as a case of ATT-induced AKI. She didn't have past exposure to rifampicin and was continuously using it this time. Conclusion: The key learning point from this case is that ATT-induced AKI can develop even when used in a continuous dosing regime and upon first time exposure despite no history of past exposure. This prompts vigilance in monitoring renal function in patients being started on ATT regimen. This is becasuse, ATT-induced AKI poses risk to patient’s life and there is a possibility of developing resistance to anti-tuberculous therapy as a result of discontinuation of treatment. Furthermore, our case suggests that, in addition to immune-mediated mechanisms described in literature for ATT-induced AKI, other pathophysiological mechanisms might also be linked to this pathology and need further research for better understanding and optimization of treatment strategies.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Cited by 3 publications

References 9 publications

Ethambutol/isoniazid/rifampicin

Ethambutol/isoniazid/rifampicin

Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia

Continuous Rifampicin Therapy Induced Acute Kidney Injury in a Tuberculous Patient: A Case Report

Contact Info

Product

Resources

About